These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 22469884

  • 1. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
    Huang X, Chen H, Han M, Zou P, Wu D, Lai Y, Huang H, Chen X, Liu T, Zhu H, Wang J, Hu J.
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1509-16. PubMed ID: 22469884
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS, Lee TJ, Kim J, Kim D.
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [Abstract] [Full Text] [Related]

  • 3. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD, Kourbeti IS, Mylonakis E.
    Clin Ther; 2014 Feb 01; 36(2):292-306.e1. PubMed ID: 24439393
    [Abstract] [Full Text] [Related]

  • 4. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
    van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, Bunin N, Wall DA, Hiemenz JW, Satoi Y, Lee JM, Walsh TJ, National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Clin Infect Dis; 2004 Nov 15; 39(10):1407-16. PubMed ID: 15546073
    [Abstract] [Full Text] [Related]

  • 5. Antifungal prophylaxis with micafungin in patients treated for childhood cancer.
    Kusuki S, Hashii Y, Yoshida H, Takizawa S, Sato E, Tokimasa S, Ohta H, Ozono K.
    Pediatr Blood Cancer; 2009 Oct 15; 53(4):605-9. PubMed ID: 19533659
    [Abstract] [Full Text] [Related]

  • 6. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
    Vehreschild MJ, von Bergwelt-Baildon M, Tran L, Shimabukuro-Vornhagen A, Wisplinghoff H, Bangard C, Cornely OA, Vehreschild JJ.
    Eur J Haematol; 2014 Nov 15; 93(5):400-6. PubMed ID: 24798021
    [Abstract] [Full Text] [Related]

  • 7. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
    Lin R, Xu X, Li Y, Sun J, Fan Z, Jiang Q, Huang F, Zhou H, Nie D, Guo Z, Mao Y, Xiao Y, Liu Q.
    Transpl Infect Dis; 2014 Apr 15; 16(2):286-94. PubMed ID: 24593273
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
    Schonfeld W, Wang Cheng J, Tong KB, Seifeldin R.
    Clin Ther; 2008 May 15; 30(5):964-73. PubMed ID: 18555943
    [Abstract] [Full Text] [Related]

  • 9. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.
    Saliba F, Pascher A, Cointault O, Laterre PF, Cervera C, De Waele JJ, Cillo U, Langer RM, Lugano M, Göran-Ericzon B, Phillips S, Tweddle L, Karas A, Brown M, Fischer L, TENPIN (Liver Transplant European Study Into the Prevention of Fungal Infection) Investigators, TENPIN Liver Transplant European Study Into the Prevention of Fungal Infection Investigators.
    Clin Infect Dis; 2015 Apr 01; 60(7):997-1006. PubMed ID: 25520332
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q, Lin MH, Chen ML, Liu ZY, Chai D, Wang R.
    Chin Med J (Engl); 2012 Jan 01; 125(2):345-51. PubMed ID: 22340571
    [Abstract] [Full Text] [Related]

  • 11. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany.
    J Antimicrob Chemother; 2006 Feb 01; 57(2):317-25. PubMed ID: 16339606
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.
    El-Cheikh J, Venton G, Crocchiolo R, Fürst S, Faucher C, Granata A, Oudin C, Coso D, Bouabdallah R, Vey N, Duran S, Fougereau E, Berger P, Chabannon C, Blaise D.
    Bone Marrow Transplant; 2013 Nov 01; 48(11):1472-7. PubMed ID: 23749104
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S, Kim K, Jang JH, Kim SJ, Kim WS, Chung DR, Kang CI, Peck KR, Jung CW.
    J Infect; 2016 Nov 01; 73(5):496-505. PubMed ID: 27394404
    [Abstract] [Full Text] [Related]

  • 14. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
    Shang W, Feng G, Sun R, Wang X, Liu W, Zhang S, Li J, Pang X, Wang Y, Zhang W.
    J Clin Pharm Ther; 2012 Dec 01; 37(6):652-6. PubMed ID: 22725946
    [Abstract] [Full Text] [Related]

  • 15. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D.
    N Engl J Med; 2007 Jan 25; 356(4):348-59. PubMed ID: 17251531
    [Abstract] [Full Text] [Related]

  • 16. Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in china.
    Wang A, Zhang Y, He L, Shen Z, Liao W, Han M, Li R, Liang D, Wu S, Hahn-Ast C, Glasmacher A, Liekwok WA.
    Jpn J Infect Dis; 2006 Dec 25; 59(6):370-6. PubMed ID: 17186955
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort.
    Cheng S, Zhou JF, Zou P, Huang XJ, Jin J, Shen ZX.
    Chin Med J (Engl); 2011 Nov 25; 124(22):3670-5. PubMed ID: 22340222
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT.
    Park HJ, Park M, Han M, Nam BH, Koh KN, Im HJ, Lee JW, Chung NG, Cho B, Kim HK, Yoo KH, Koo HH, Kang HJ, Shin HY, Ahn HS, Lim YT, Kook H, Lyu CJ, Hah JO, Park JE, Lim YJ, Seo JJ.
    Bone Marrow Transplant; 2014 Sep 25; 49(9):1212-6. PubMed ID: 25000455
    [Abstract] [Full Text] [Related]

  • 19. Micafungin as antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: results of different dosage levels in clinical practice.
    Langebrake C, Rohde H, Lellek H, Wolschke C, Kröger NM.
    Clin Transplant; 2014 Mar 25; 28(3):286-91. PubMed ID: 24479680
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW, Bryar JM, McDonnell AM, Delgado-Flores JO, Mui E, Baden LR, Marty FM.
    Clin Ther; 2010 Apr 25; 32(4):637-48. PubMed ID: 20435233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.